Upcoming Medical Conferences in LisbonSearch Criteria : Portugal Lisbon
Feb 12 - 13, 2020 | Lisbon, Lisbon
CannX Lisbon: The International Medical Cannabis Conference is organized by Kenes Group and will be held from Feb 12 - 13, 2020 at PT Meeting Center, Lisbon, Portugal. Description: Europe is poised for change with a recent flurry of activity around medical cannabis reform and legislation, and Portugal in particular, plays a key role in this expanding market. The conference will be preceded by a full-day medical course, “Introduction to Endocannabinology and Medical Cannabis,” taking place on Tuesday, 11 February. With hundreds of attendees, CannX is the ultimate platform for the exchange of high-level scientific knowledge, professional expertise and valuable networking opportunities. An application will be made to the European Accreditation Council for Continuing Medical Education (EACCME) for CME accreditation of CannX Lisbon. The EACCME is an institution of the European Union of Medical Specialists (UEMS) The main program includes 3 exciting tracks – Science, Business, and Agriculture. SCI: • The Latest in Medical Cannabis Research • Autoimmune Diseases • Mental Health Disorders • Neuroprotection and Neuroregeneration • Cannabinoids Mechanism of Action • Medical Grade Cannabis • Patient Wellbeing – Risk and Side Effect Management • THC and CBD Interactions • Dependency • The Endocannabinoid System as an Emerging Target of Pharmacotherapy • New Clinical Research on Various Diseases – Dementia, Autism, Diabetes, Tourette’s Syndrome, Gynecological Diseases, Cardiovascular Conditions BIZ: • Entering the Pharmaceutical Industry – How to Meet Pharma Standards • How to Assess the True Value of a Company • Global Trade – Regulation and Standardization • Dosage and Delivery Methods • Digital Health • Ethical Issues • How to Regulate Medical Cannabis for the Safety and Satisfaction of Public • Policy, the Industry and the Patients AGR: • Advanced Growing Technologies – Tissue Culture Technologies, Vertical Growing • Cannabis Farm Management Software • New developments in Genetics • Plant Control and Testing: How to Grow Top Quality Crops
On 20 & 21 February 2020, Lisbon (Portugal) will host the BioTech Pharma Summit: Liquid Biopsy 2020 conference. This year’s event will bring together the leaders in the field from pharma, biotech, Dx companies and healthcare and be the home of multi-stakeholder and pan-industry collaboration for liquid biopsy, molecular pathology and precision medicine experts to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as application of liquid biopsy testing, across biofluids, biomarkers and disease indications, as the needle shifts on the gold standard of personalized healthcare testing. Who Should Attend? The BioTech Pharma Summit (EPM Group) are exclusive events consisting of world-class keynote addresses and presentations designed specifically for senior level attendees from research & academic institutions, clinical research institutions and hospital laboratories as well as major pharmaceutical and biotech companies based Worldwide. Delegates typically include CEOs, VPs, Drug developers, Academics and Researchers, CROs, Scientists and Medical Doctors of: • Liquid biopsy • Clinical Pathology • Molecular Assay Development • Medical Laboratory • Scientific Affairs • Sales and Marketing • Quality Management • Process Development • Commercial & Outreach, Oncology • Molecular pathology • Research Scientist • Molecular Biology • Sales & Business Development • Clinical and Translational Affairs • Clinical Research • Companion Diagnostics • Biomarkers • Manufacturing • Clinical Trial • Oncology Business Development • Precision medicine • Clinical Laboratory • Immunochemistry • Cell Culture • Clinical Genomics Key Practical Learning Points: • Liquid Biopsy: New Opportunities, Technologies, and Challenges in the Field • Clinical integration of liquid biopsy • Circulating Tumor Cells: History and Future Perspectives • Improving the Quality of Circulating Tumor DNA Measurements • Circulating Tumor Cells in Monitoring Cancer • Extracellular vesicles (Evs) • New Tools for Liquid Biopsies: Microfluidic Platforms for the Isolation of CTCs, cfDNA and Exosomes • CTC Isolation Platforms and Using CTCs for Monitoring Therapy Responses • Dissecting Mechanisms of Breast Cancer Metastasis Using Patient Derived Circulating Tumor Cells • Liquid Biopsies in Cancer Immunotherapy Clinical Drug Development • Heterogeneity of Cancer-Derived Extracellular Vesicles • Liquid Biopsies in Oncology and the Current Regulatory Landscape • Validating Liquid Biopsies in Cancer • ctDNA Liquid Biopsy Assay Description: The field of liquid biopsy is moving beyond isolation and characterization of CTCs and ctDNA to surveillance, early detection of relapse and minimal residual disease, and interventional studies in clinical applications. The scope of the conference encompasses circulating tumor cells, cell-free circulating DNA, exosomes and extracellular vesicles. This meeting has become an important annual event for leaders in the community to discuss the tools, validation and implementation of circulating biomarkers, which are transforming our understanding and management of disease. The BioTech Pharma Summit: Liquid Biopsy 2020 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.
Feb 24 - 26, 2020 | EUR €549 | Lisbon, Lisbon
Healthcare Technologies & Public Health Conference | February 24-26, 2020 | Lisbon, Portugal Top Healthcare Conferences 2020 | Top Occupational Health 2020 Conferences | Best Public Health Congress 2020 | Global Nursing Summit 2020 | World Diabetes Conference 2020 | Lisbon Healthcare League 2020 Healthcare League 2020, Portugal organized by Yuktan Technologies Pvt. Ltd, Indonesia jointly in the collaboration with GED Biomedical Innovations (BMI AB, Sweden) extends a sincere welcome to all the eminent Nobel Laureates, Speakers, Delegate and Healthcare Professionals, Nutritionists and Pharmacists from all around the Globe to Lisbon for attending our International Healthcare Technologies & Public Health Conference 2020 during February 24-26, 2020 in Lisbon, Portugal. The main focus of the league pointed towards “Welcoming to explore new dimensions of Healthcare, Public health & safety and for a better future” has aimed to bring together Global leading Health-care Professional, Medical Officers, Pharmacists & Healthcare Specialists, Occupational Health Care Administrators, Healthcare Industries, Medical Researchers, Global Environmentalists, Industrialists, Health Insurance Policy Makers and Academicians, including Nobel Laureates, Delegates, Professors and others to exchange and share their experiences and research results regarding all aspects of Healthcare Technologies and Public Health. This conference will focus on a variety of Healthcare topics includes but not limited to Women Healthcare, Occupational Health, Health Issues regarding Food safety, Diseases and Preventive Care, Paediatrics, Nanomedicines, Healthy Work Environment, Hazardous Drugs, Modern Preventive Care, Fire Safety, Workplace Violence, HIV & AIDS, Global Warming, Viral Oncology, Medical Safety Devices, Cancer & Treatment, Diabetes & Care, Agriculture & Environment Safety, Pharmaceuticals & Technologies, Pharmacology & and Future Steps & Goals towards development Healthcare and Public Safety goals through requested presentation, workshops, respective sessions includes both oral and poster sessions of spontaneous contributions. Connect with us on these three intensive and interesting days of discussion on contemporary Healthcare Technologies and Public Health & Safety. We invite you to contribute and help to shape the conference through submissions of your research abstracts for Keynote, Oral presentation or Posters presentation. Further details about Healthcare League, kindly follow the link: http://healthcareconference.yuktan.com/ For brief details of our Congress Sessions kindly follow the link: http://healthcareconference.yuktan.com/abstract-submission.php Who Should Attend: • Healthcare Professionals • Doctors • Dermatologists • Pharmacists • Researchers & Scientists • Emergency & Serious Care • Cardiologists • Psychiatrists etc. Why Attend: A great opportunity to network with your peers from academia and industry: • Creative Speakers & Panel Discussions • Interactive Poster Session • Emerging Researcher Forum • Networking & Collaboration • Opportunity to organize Workshop/Symposium Sessions: • Occupational Health and Safety • Healthcare Psychology • Healthcare Services and Technologies • Healthcare Oncology and Treatment • Public Health and Epidemiology • HIV & AIDS • Cardiology • Pharmaceutical Medicine Warm Regards Arnab Das Program Manager | Healthcare League 2020
Mar 02 - 04, 2020 | EUR €595 | Lisbon, Lisbon
EACR-AACR-ASPIC 2020 Conference: Tumor Microenvironment is organized by European Association for Cancer Research (EACR), American Association for Cancer Research (AACR), Portuguese Association for Cancer Research / Associacao Portuguesa De Investigacao Em Cancro (ASPIC) and will be held from Mar 02 - 04, 2020 at Congress Center Lisboa, Lisbon, Portugal. Topics to be covered This Conference will bring together thought leaders spanning the breadth of TME, immune-oncology, computational biology, and biomedical technology disciplines to discuss novel approaches to identify critical mechanisms regulating the crosstalk in these tumor ecosystems. They will also discuss therapeutic approaches to target the TME for durable tumor control, including strategies being deployed in patients, and initial clinical findings. The goal will be to not only discuss the current state of the TME field, but also discuss approaches towards applying that knowledge to the development of effective and broadly applicable anti-cancer therapies for long-term management of disease. Background: Cancers are communities of cells, including those harboring genetic mutations, aka “tumor” or “cancer” cells, as well as other “normal” cell types activated and/or recruited to the local tumor microenvironment (TME). Components of the TME (e.g., blood and lymphatic vessels, fibroblasts and other mesenchymal support cells, innate and adaptive immune cells, as well as extracellular matrix, hypoxia, and low pH), while regulating or being regulated by hallmark features of cancer development, can also thwart efficacy of cytotoxic, targeted and immune therapies. Abstract submission topics: TUMOR MICROENVIRONMENT (TME): • Single-cell analysis of the TME • 2D and 3D analysis/imaging of the TME • Inflammation, cancer immunity and TME • Metastases and the TME • Vascular (hematogenous & lymphatic) biology in the primary and metastatic TME • TME dynamics and cancer therapy sensitivity/resistance • Lipids, cancer metabolism, and TME Additional details will be posted as soon as information is available.
Mar 26 - 28, 2020 | EUR €560 | Lisbon, Lisbon
The 11th Annual Congress on Controversies in Ophthalmology: Europe (COPHy EU) is organized by ComtecMed. The symposium is held from Mar 26 - 28, 2020 at EPIC SANA Lisboa Hotel, Lisbon, Portugal. Description: The COPHy EU program, turning to Lisbon in 2020, the session holds the evidence-based debates and conversations amongst the arbitrators, speakers, and the audience, who will examine and analyze the most important and controversial concerns raised during the course of 2019 and 2020 in the area of ophthalmology. This educational Congress is solely focused on Retina but will also discuss controversies on other related areas of ophthalmology that includes neuro-ophthalmology, ocular imaging, and uveitis. Topics in the session will cover the medical and surgical treatment of retinal diseases that includes the age-related macular degeneration, diabetic macular edema, proliferative diabetic retinopathy, retinal vein occlusions, pathologic myopia, and vitreomacular interface abnormalities, as well as advances in ophthalmic imaging, hereditary retinal diseases, surgical innovations, home monitoring, and the role of deep learning (artificial intelligence) in these conditions. Bestows ample of time for speaker-audience discussion, the session intends to reach up-to-date references on ongoing debates even when data remain limited, through evidence-based medicine, including expert opinion. Attendees will have a chance to take part in this vibrant meeting which will promote discussions on the shared experiences and opinions of leading local and international experts. The 11th COPHy EU Congress will highlight the issues related to the region in terms of diagnostics, characteristic responses to treatments and typical complications. Most of the Faculty members will be from Portugal and Spain in order to discuss these typical regional problems. Additional details will be posted as soon as they are available.
May 18 - 20, 2020 | Lisbon, Lisboa
European Association for Cancer Research (EACR) - Organization of European Cancer Institutes (OECI) Joint Conference: Molecular Pathology Approach to Cancer is organized by European Association for Cancer Research (EACR), Organization of European Cancer Institutes (OECI) and will be held from May 18 - 20, 2020 at Lisbon, Portugal. Target audience This conference will be of interest to a diverse audience including pathologists, molecular pathologists and pathology residents, researchers in the field of molecular diagnostics and precision oncologists. The conference population will thus simulate the multidisciplinary teams that act in the real world to facilitate interdisciplinary research and the multidisciplinary teams caring for patients with cancer. Description: Molecular pathology is revolutionising clinical practice in oncology and pathology paving the way for precision medicine, and has evolved into a growing research field. Knowledgeable molecular pathologists are a significant bottle neck for advancing cancer research and patient care. This meeting will provide participants with a broad view of the scope, methodologies, future directions and challenges in addition to practical approaches for molecular pathology in research and in clinical settings. The potential uses of deep learning in pathology will be discussed. The meeting will help participants to establish a network of interactions and to build bridges to foster cross disciplinary studies. We are preparing into the future and to face the still unknown discoveries to come. Topics to be covered • Current views on molecular pathology • Molecular pathology of colorectal cancer • Molecular pathology of lung cancer • Cancer models for biomarker discovery, from animal models to patient derived organoids • New technologies in diagnostic onco-pathology. Additional details will be posted as soon as they are available.
Jun 10 - 13, 2020 | Lisbon, Lisbon
XXVII European Congress of Perinatal Medicine (ECPM) is organized by MCA Scientific Events, the European Association of Perinatal Medicine (EAPM). The session is held from Jun 10 - 13, 2020 at Centro Cultural de Belém, Lisbon, Portugal. Description: European Congress of Perinatal Medicine is arranged for every 2 years in one of any major European city. The 27th Edition of the European Congress of Perinatal Medicine (ECPM) is originally organized by the European Association of Perinatal Medicine (EAPM). The goals of the session include promoting and disseminating the study, rendering the research and knowledge on all aspects of perinatal medicine, to accomplish the optimal physical and mental health for mothers and their children by enhancing the status and provision of perinatal care in Europe. Main Topics of ECPM 2020: • Doctors and Midwives; care or cure • Fetal Growth Restriction • Infection & Surroundings • Maternal psychiatric disorders and pregnancy • Neuroscience ( the fetal and neonatal brain) • Quality improvement and perinatal networks Pre Congress courses Jun 10, 2020 Additional details will be posted as soon as information is available.
Jun 17 - 20, 2020 | Lisbon, Lisbon
21st World Congress On Dental Traumatology (WCDT) is organized by International Association Dental Traumatology (IADT), European Society of Endocrinology (ESE) and will be held from Jun 17 - 20, 2020 at Congress Center Lisboa, Lisbon, Portugal. The theme of the congress is: "Challenges, Opportunities and New Horizons in Dental Trauma" Course Description: World Congresses on Dental Traumatology are universally known as extraordinary meetings that combine the diagnosis and treatment of patients who have sustained an oral or dental traumatic injury, with the latest advances in the biological and materials sciences. Pre-congress courses will be held on 17th June with the main programme starting on Thursday 18th June 2020. Additional details will be posted as soon as they are available.
Jul 14 - 17, 2020 | EUR €1728 | Lisbon, Lisbon
Animal Models of Cancer Conference: From Cancer Genetics to Precision Oncology is organized by Fusion Conferences Ltd and will be held from Jul 14 - 17, 2020 at Dolce CampoReal Lisboa, Lisbon, Portugal. Target Audience: • Basic scientists studying all aspects of cancer biology • Scientists and clinicians performing translational work, especially those using mouse models for preclinical studies • Investigators from the biotech and pharma industries who are interested in state-of-the-art animal modeling approaches Description: The first genetically engineered mice were created more than 40 years ago. Since then, steady improvements in the field have allowed for the generation of experimentally controllable and genetically accurate models for many human cancers. Recent technological advances in genome editing are pushing this frontier and new animal models are directly impacting precision medicine approaches by enabling the functional evaluation of larger numbers of genetic and epigenetic alterations, by providing pre-clinical and co-clinical platforms to evaluate new therapies, and by allowing for the detailed study of tumor biology that cannot be approached in cell-based systems, immunocompromised animals, or patients. While animal modeling has been a staple of the cancer biology community for decades, it is only now maturing to its fullest potential. This conference will focus on three major areas: First, it will present new approaches to generate precise and complex genetic alterations in mice and other animals to better “humanize” models and allow for in vivo studies of cancer gene function. Second, it will highlight studies to investigate fundamental mechanisms of cancer initiation and progression, including the cell of origin of tumors, their evolution, their metabolism, and their interactions with the immune system. Finally, the meeting will explore how genetically engineered animal models can help evaluate the efficacy of novel therapeutic approaches and to decipher mechanisms of therapeutic resistance. Educational Need: Cancer genome sequencing provides an unprecedented view of recurrent alterations in human cancers and the development of highly effective targeted therapies and immune-modulatory therapies constitutes major victories. Nevertheless, the function of genes identified from genomic studies is often poorly characterized, leaving no means of therapeutic intervention. Moreover, cancers that are initially sensitive to therapy inevitably become resistant, often through mechanisms that are not well understood. Mouse models represent an experimental system to study cancer gene function and to evaluate the efficacy and resistance mechanisms associated with specific therapies. In the past few years, other animal models have also been instrumental in studying mechanisms of tumorigenesis. This conference will provide a forum for discussion on the past, present, and future of animal models for cancer, in particular the role that these models will play in the era of precision medicine. Key Sessions: • New technologies for cancer modelling • Modeling pre-cancers and tumor initiation • Cancer metabolism • Cancer/immune interactions and tumor microenvironment • Metastasis • Preclinical trials and resistance
Jul 17 - 20, 2020 | USD $1718 | Lisbon, Lisbon
Intestinal Stem Cell - Niche Interactions in Health and Disease Conference is organized by Fusion Conferences Ltd and will be held from Jul 17 - 20, 2020 at Dolce CampoReal Lisboa, Lisbon, Portugal. Target Audience: Scientists and physicians from the fields of stem cell biology, gastrointestinal disease, metabolic disorders, or immunology who are interested in integrating concepts across these areas to improve understanding of mechanisms underlying intestinal homeostasis, disease, and disease treatment. Key Sessions: Inflammation: causes and consequence • Microbiome • Metabolism and Aging • Modeling the intestine in vitro • Intestinal diseases and ISCs • Plasticity in the intestine • Regulation of ISC behavior Synopsis: The past ten years have seen an explosion of information regarding intestinal stem cells (ISCs), due to an improved ability to identify ISCs, follow their fates, and manipulate ISCs in vitro. The next frontier in the ISC field is understanding the role that dysregulated ISC behavior plays in the etiology of disease, and conversely, the impact of intestinal disease on proper ISC function. This meeting will bring together a diverse group of investigators to discuss topics such as how the environment of the small intestine and colon impacts ISC behavior in healthy and diseased states, how ISC behavior and the niche differ along the proximal-distal axis of the intestine, and the strengths of various models for investigating the relationship between ISCs, the niche, and the onset and propagation of disease states. Educational Need: There does not appear to be any other conference which focuses entirely on intestinal stem cell biology in the context of multiple disease states and in a variety of organisms. In the conference, we will discuss topics such as: • Novel methods for assessing stem cell growth and differentiation capabilities from along the intestinal tract • Discussing the extent to which mouse studies can faithfully model human disease, and what are the limits • The impact of inflammation (disease, infection) on ISC proliferation and differentiation capacity • The impact of diet and metabolism on ISC behaviour from different regions of the small and large intestine • The impact of aging on ISCs from different regions of the small and large intestine